Real-world outcomes of adjuvant therapy in melanoma: an Italian referral center experience

Real-world outcomes of adjuvant therapy in melanoma: an Italian referral center experience

Saved in:

Bibliographic Details
Main Authors:	G. Roccuzzo, G. Carpentieri, E. Bongiovanni, U. Santaniello, V. Pala, P. Fava, S. Ribero, P. Quaglino
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	EJC Skin Cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772611824001757
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Updates on CTCL diagnostic and therapeutic trends amidst the COVID-19 pandemic: insights from a referral center
by: G. Roccuzzo, et al.
Published: (2024-01-01)

Insights on different erythroderma features in Sezary syndrome: a prospective validation study
by: G. Roccuzzo, et al.
Published: (2024-01-01)

Circulating tumor DNA: a promising biomarker in stage III BRAF+ melanoma
by: G. Roccuzzo, et al.
Published: (2024-01-01)

Monitoring circulating tumor DNA liquid biopsy in stage III BRAF-mutant melanoma patients undergoing adjuvant treatment
by: Sara Marchisio, et al.
Published: (2024-11-01)

Real-world outcomes for advanced melanoma in the adjuvant and unresectable setting: Single-center registry analysis
by: R. Staeger, et al.
Published: (2024-01-01)

Real‐World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma
by: Wolfram Samlowski, et al.
Published: (2023-02-01)

Early recurrence in a pooled international cohort of melanoma patients treated with adjuvant nivolumab in a real-world setting
by: L. Mortier, et al.
Published: (2024-01-01)

Real-World efficiency of pembrolizumab in metastatic melanoma patients following adjuvant anti-PD1 treatment
by: Michael Weichenthal, et al.
Published: (2024-12-01)

Outcomes of definitive radiotherapy vs. laryngectomy followed by adjuvant radiotherapy in patients with locally advanced laryngeal squamous cell carcinoma: real-world experience in a referral cancer center
by: Ali Kazemian, et al.
Published: (2024-12-01)

Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France
by: S. Dalle, et al.
Published: (2024-01-01)

APAVAC Immunotherapy for the Adjuvant Treatment of a Canine Mucosal Melanoma
by: Valentina Rinaldi, et al.
Published: (2024-12-01)

Predictors of recurrence and progression in poorly differentiated cutaneous squamous cell carcinomas: insights from a real-life experience
by: G. Roccuzzo, et al.
Published: (2024-01-01)

PIK3CA testing in HR+/HER2− Metastatic Breast Cancer: Real-world data from referral molecular pathology labs
by: K. Venetis, et al.
Published: (2023-11-01)

Adjuvant and neoadjuvant immunotherapy for acral and mucosal melanoma
by: Takaya Komori, et al.
Published: (2025-01-01)

Eosinophilic Asthma Secondary to Adjuvant Anti-PD-1 Immune Checkpoint Inhibitor Treatment in a Melanoma Patient
by: P. Kissoonsingh, et al.
Published: (2022-01-01)

Adjuvant lymph node radiotherapy and immunotherapy in stage III melanoma
by: L. Marxgut, et al.
Published: (2024-01-01)

Effectiveness, speed of action and safety of brodalumab in elderly psoriasis patients: a multicenter real-world study – IL PSO (Italian Landscape Psoriasis)
by: D. Orsini, et al.
Published: (2025-12-01)

Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study – IL PSO (Italian Landscape Psoriasis)
by: D. Orsini, et al.
Published: (2024-12-01)

First-line Nivolumab plus Ipilimumab in patients with advanced melanoma previously treated with adjuvant systemic therapy
by: K. Kisielewska, et al.
Published: (2024-01-01)

Recurrent Pericarditis, an Unexpected Effect of Adjuvant Interferon Chemotherapy for Malignant Melanoma
by: Farhan Ashraf, et al.
Published: (2016-01-01)

Comparative Analysis of Pembrolizumab Dosing Schedules in the Adjuvant Treatment of Malignant Melanoma
by: Y. Ahmed, et al.
Published: (2024-01-01)

Immune-related adverse events with adjuvant anti-PD-1 therapy in high-risk resected melanoma: a single-center experience
by: I. Csányi, et al.
Published: (2024-01-01)

Real-World Experience with Cangrelor as Adjuvant to Percutaneous Coronary Intervention: A Single-Centre Observational Study
by: Troels Thim, et al.
Published: (2023-01-01)

Real-World Evaluation of ImmuCare Patient-Reported Outcomes in Melanoma Patients Treated with Immune-Checkpoint Inhibitors
by: S. Belkaïd, et al.
Published: (2024-01-01)

Adjuvant immunotherapy after neoadjuvant immunochemotherapy and esophagectomy for esophageal squamous cell carcinoma: a real-world study
by: Jifeng Feng, et al.
Published: (2024-12-01)

Prognosis and cardiotoxicity associated to adjuvant trastuzumab for breast cancer: real world study in a public health system
by: Ana Elisa Ribeiro da Silva Cabello, et al.
Published: (2025-01-01)

Fuchs’ Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis
by: Massimo Accorinti, et al.
Published: (2016-01-01)

Exploring “Decision regret” in Adjuvant-Treated Melanoma Patients– results from a cross-sectional survey on 200 participants
by: T. Grünke, et al.
Published: (2024-01-01)

Real-world clinical and psychosocial outcomes among people with mild or moderate haemophilia A treated on-demand in the Italian CHESS II cohort: a real-world data analysis
by: Castaman Giancarlo, et al.
Published: (2024-04-01)

Cost–Benefit Analysis of in vivo Reflectance Confocal Microscopy for Melanoma Diagnosis in a Real-World Clinical Setting
by: Bruno GM, et al.
Published: (2025-01-01)

Characteristics of the First Italian Older Adults Vaccinated with an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine
by: Alexander Domnich, et al.
Published: (2025-01-01)

Ranibizumab for Visual Impairment due to Diabetic Macular Edema: Real-World Evidence in the Italian Population (PRIDE Study)
by: Ugo Menchini, et al.
Published: (2015-01-01)

The clinical utility of comprehensive genomic profiling tests for patients with advanced malignant melanoma in a real-world setting: A retrospective analysis from a single cancer center
by: Y. Matsui, et al.
Published: (2024-01-01)

Real-world effectiveness of dabrafenib and trametinib in patients with BRAF-positive melanoma treated in routine Bulgarian clinical practice
by: Alexandra Savova, et al.
Published: (2024-12-01)

Neoadjuvant ipilimumab plus nivolumab in locally advanced melanoma: A real-world single-centre retrospective study
by: Patrick Schummer, et al.
Published: (2023-01-01)

Long term survival following cryoablation with adjuvant Toripalimab for anorectal malignant melanoma: a case report
by: Xuejun Jiang, et al.
Published: (2025-01-01)

Liquid biopsy for lung cancer: A cross section on the diagnostic routine experience of a referral Italian institution
by: Caterina de Luca, et al.
Published: (2023-12-01)

Rechallenge and retreatment with topical imiquimod 5% in transplant recipients: A multicenter experience on actinic keratoses and basal cell carcinomas
by: Paolo Fava, et al.
Published: (2024-12-01)

Use of real-world evidence in postmarketing medicines regulation in the European Union: a systematic assessment of European Medicines Agency referrals 2013–2017
by: Kevin Wing, et al.
Published: (2019-10-01)

PRospective Evaluation of natriuretic peptide-based reFERral of patients with chronic heart failure in primary care (PREFER): a real-world study
by: Yigal M Pinto, et al.
Published: (2021-12-01)